Tae Il Noh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tae Il Noh has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Seok Ho Kang
Department of Urology, Korea University Anam Hospital, Korea University Medical Center, Korea University School of Medicine, Seoul, Korea
11 shared publications - Ji Sung Shim
Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
8 shared publications - Sung Gu Kang
Department of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea
8 shared publications - Sung Goo Yoon
Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
6 shared publications - Min Gu Park
Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea
5 shared publications - Seong Woo Yun
Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (3) , 246-253
Impact of carcinoma in situ of bladder at transurethral resection and radical cystectomy on survival: Retrospective multicenter study
Heo JE, et al. Investig Clin Urol. 2026 ;67:e24. https://doi.org/10.4111/icu.20250455
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (3) , 246-253
Open AccessImpact of carcinoma in situ of bladder at transurethral resection and radical cystectomy on survival: Retrospective multicenter study
Heo JE, et al. Investig Clin Urol. 2026 ;67:e24. https://doi.org/10.4111/icu.20250455
- Open Access
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (2) , 148-161
Long-term oncologic outcomes of robot-assisted radical cystectomy: Prognostic indicators and complication profiles from a high-volume single-surgeon series
Yoon SG, et al. Investig Clin Urol. 2026 Mar;67(2):148-161. https://doi.org/10.4111/icu.20250512
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (2) , 148-161
Open AccessLong-term oncologic outcomes of robot-assisted radical cystectomy: Prognostic indicators and complication profiles from a high-volume single-surgeon series
Yoon SG, et al. Investig Clin Urol. 2026 Mar;67(2):148-161. https://doi.org/10.4111/icu.20250512
- Top Cited PapersOpen Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (1) , 36-48
Nocturia, Sleep Quality, and Mortality: A Systematic Review and Meta-Analysis
Lavadia AC, et al. World J Mens Health. 2026 Jan;44(1):36-48. https://doi.org/10.5534/wjmh.240237
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (1) , 36-48
Top Cited PapersOpen AccessNocturia, Sleep Quality, and Mortality: A Systematic Review and Meta-Analysis
Lavadia AC, et al. World J Mens Health. 2026 Jan;44(1):36-48. https://doi.org/10.5534/wjmh.240237
- Open Access
- 1 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7762
Towards an Improved Standard in Penile Duplex Doppler Ultrasonography: A Randomized Crossover Trial of 3D Virtual Glasses for Audiovisual Sexual Stimulation
Background/Objectives: We compared the efficacy of audiovisual sexual stimulation (AVSS) using 3D virtual glasses with a desktop monitor. Methods: In this randomized crossover study, 60 patients with ED underwent two penile duplex Doppler ultrasound sessions 1 week apart, each after intracavernosal prostaglandin E1 injection. Patients were randomly assigned to receive AVSS via 3D virtual glasses or a desktop monitor in the first session, with crossover in the second. We measured the resistive index (RI), erectile hardness score (EHS), peak systolic velocity (PSV), anxiety (State-Trait Anxiety Inventory), and satisfaction (visual analog scale). Results: 3D virtual glasses were associated with superior outcomes. The linear mixed models analysis showed higher adjusted mean RI (p < 0.001), PSV (p < 0.001), and satisfaction (p < 0.001) for 3D glasses. Generalized estimating equations analysis showed patients were 6.68 times more likely to achieve functional erection (EHS ≥ 3) with 3D glasses (odds ratio 6.68, 95% confidence interval [2.54, 17.55], p < 0.001). Anticipatory anxiety before subsequent examinations was lower with virtual glasses (p < 0.001). Conclusions: AVSS with 3D virtual glasses is associated with superior hemodynamic parameters and clinical responses consistent with reduced false-positive diagnoses. It also lowers anticipatory anxiety for subsequent procedures, enhancing patient experience.
- 1 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7762
Open AccessTowards an Improved Standard in Penile Duplex Doppler Ultrasonography: A Randomized Crossover Trial of 3D Virtual Glasses for Audiovisual Sexual Stimulation
Background/Objectives: We compared the efficacy of audiovisual sexual stimulation (AVSS) using 3D virtual glasses with a desktop monitor. Methods: In this randomized crossover study, 60 patients with ED underwent two penile duplex Doppler ultrasound sessions 1 week apart, each after intracavernosal prostaglandin E1 injection. Patients were randomly assigned to receive AVSS via 3D virtual glasses or a desktop monitor in the first session, with crossover in the second. We measured the resistive index (RI), erectile hardness score (EHS), peak systolic velocity (PSV), anxiety (State-Trait Anxiety Inventory), and satisfaction (visual analog scale). Results: 3D virtual glasses were associated with superior outcomes. The linear mixed models analysis showed higher adjusted mean RI (p < 0.001), PSV (p < 0.001), and satisfaction (p < 0.001) for 3D glasses. Generalized estimating equations analysis showed patients were 6.68 times more likely to achieve functional erection (EHS ≥ 3) with 3D glasses (odds ratio 6.68, 95% confidence interval [2.54, 17.55], p < 0.001). Anticipatory anxiety before subsequent examinations was lower with virtual glasses (p < 0.001). Conclusions: AVSS with 3D virtual glasses is associated with superior hemodynamic parameters and clinical responses consistent with reduced false-positive diagnoses. It also lowers anticipatory anxiety for subsequent procedures, enhancing patient experience.
- 2 July 2025
- Published by Wiley in The Prostate
- Vol. 85 (13) , 1161-1167
The Efficacy of Transperineal Drainage for Treating Prostatic Abscess: A Comparative Analysis Against Conservative Management
Background: Prostatic abscess (PA) is an uncommon but serious urological condition requiring immediate intervention. Both drainage and conservative treatment are feasible because there are currently no well‐established treatment guidelines. This study aimed to compare the clinical outcomes and mortality rates between patients who underwent transperineal prostatic abscess drainage (TPAD) and those who underwent conservative management.Methods: We analyzed 41 patients diagnosed with PA using computed tomography, magnetic resonance imaging, and transrectal ultrasonography between December 2021 and July 2024. The patients underwent either TPAD or conservative management. Conservative management consisted of intravenous antibiotics as the mainstay of therapy, whereas the intervention group received TPAD in addition to antibiotic therapy. TPAD was performed under local anesthesia with the patient in the lithotomy position. All patients were discharged after the normalization of inflammatory markers and body temperature.Results: Of the initial total of 41 patients, 6 were excluded based on the exclusion criteria. Among the remaining 35 enrolled patients, 18 underwent TPAD and 17 received conservative management. There were no significant differences in age, number of comorbidities, or prostate‐specific antigen levels between the two groups; however, the TPAD group exhibited a significantly larger abscess size (p = 0.000), shorter hospital stay (p = 0.041), and lower mortality (p = 0.045).Conclusions: In the absence of standardized treatment guidelines, TPAD which can be easily implemented, is considered a favorable treatment method that can reduce the length of hospital stay, recurrence rates, and mortality rates compared with conservative treatment.
- 2 July 2025
- Published by Wiley in The Prostate
- Vol. 85 (13) , 1161-1167
The Efficacy of Transperineal Drainage for Treating Prostatic Abscess: A Comparative Analysis Against Conservative Management
Background: Prostatic abscess (PA) is an uncommon but serious urological condition requiring immediate intervention. Both drainage and conservative treatment are feasible because there are currently no well‐established treatment guidelines. This study aimed to compare the clinical outcomes and mortality rates between patients who underwent transperineal prostatic abscess drainage (TPAD) and those who underwent conservative management.Methods: We analyzed 41 patients diagnosed with PA using computed tomography, magnetic resonance imaging, and transrectal ultrasonography between December 2021 and July 2024. The patients underwent either TPAD or conservative management. Conservative management consisted of intravenous antibiotics as the mainstay of therapy, whereas the intervention group received TPAD in addition to antibiotic therapy. TPAD was performed under local anesthesia with the patient in the lithotomy position. All patients were discharged after the normalization of inflammatory markers and body temperature.Results: Of the initial total of 41 patients, 6 were excluded based on the exclusion criteria. Among the remaining 35 enrolled patients, 18 underwent TPAD and 17 received conservative management. There were no significant differences in age, number of comorbidities, or prostate‐specific antigen levels between the two groups; however, the TPAD group exhibited a significantly larger abscess size (p = 0.000), shorter hospital stay (p = 0.041), and lower mortality (p = 0.045).Conclusions: In the absence of standardized treatment guidelines, TPAD which can be easily implemented, is considered a favorable treatment method that can reduce the length of hospital stay, recurrence rates, and mortality rates compared with conservative treatment.
- Open Access
- 1 July 2025
- Published by Korean Society of Endourology and Robotics in Theater in Endourology and Robotics
- Vol. 1 (1) , 9-12
Tips and tricks to improve functional outcomes in robot-assisted radical cystectomy
Sung Goo Yoon, Hyun Jung Jin, Tae Il Noh, Ji Sung Shim, Min Gu Park, Sung Gu Kang, Seok Ho Kang. Theater Endourol. Robot. 2025;1:9-12. https://doi.org/10.64364/tier.10105
- 1 July 2025
- Published by Korean Society of Endourology and Robotics in Theater in Endourology and Robotics
- Vol. 1 (1) , 9-12
Open AccessTips and tricks to improve functional outcomes in robot-assisted radical cystectomy
Sung Goo Yoon, Hyun Jung Jin, Tae Il Noh, Ji Sung Shim, Min Gu Park, Sung Gu Kang, Seok Ho Kang. Theater Endourol. Robot. 2025;1:9-12. https://doi.org/10.64364/tier.10105
- Open Access
- 31 March 2025
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 23 (1) , 79-87
Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Purpose: To evaluate whether extended pelvic lymph node dissection (PLND) improves survival outcomes compared with standard PLND in patients with bladder cancer (BCa) undergoing radical cystectomy (RC), and to assess its potential benefits in patients with prior or concurrent radical nephroureterectomy (p/cRNU).Materials and Methods: A multicenter analysis included 2202 patients with BCa undergoing RC with standard or extended PLND at 11 tertiary centers from 2003 to 2023. Following propensity score matching, 659 pairs (n=1,318), including 128 patients with p/cRNU, were analyzed. Recurrence-free survival (RFS) was the primary outcome, while overall survival (OS), cancer-specific survival (CSS), and readmission rates were secondary outcomes. Survival analyses performed using Kaplan-Meier methods and clustered Cox models.Results: Extended PLND yielded significantly more lymph nodes than standard PLND (median: 27.0 vs. 17.0, p0.05). Extended PLND increased readmission rates (28.4% vs. 20.2%, p=0.001) and readmission risk (odds ratio, 1.57; 95% confidence interval [CI], 1.15–2.16, p=0.005). However, subgroup analysis revealed extended PLND significantly improved RFS in patients with p/cRNU (hazard ratio, 0.54; 95% CI, 0.38–0.77; p<0.001).Conclusion: Extended PLND does not provide survival benefits for overall patient population and increases readmission risk but significantly improves RFS in patients with p/cRNU. Tailoring PLND extent based on upper tract disease status is recommended.
- 31 March 2025
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 23 (1) , 79-87
Open AccessImpact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Purpose: To evaluate whether extended pelvic lymph node dissection (PLND) improves survival outcomes compared with standard PLND in patients with bladder cancer (BCa) undergoing radical cystectomy (RC), and to assess its potential benefits in patients with prior or concurrent radical nephroureterectomy (p/cRNU).Materials and Methods: A multicenter analysis included 2202 patients with BCa undergoing RC with standard or extended PLND at 11 tertiary centers from 2003 to 2023. Following propensity score matching, 659 pairs (n=1,318), including 128 patients with p/cRNU, were analyzed. Recurrence-free survival (RFS) was the primary outcome, while overall survival (OS), cancer-specific survival (CSS), and readmission rates were secondary outcomes. Survival analyses performed using Kaplan-Meier methods and clustered Cox models.Results: Extended PLND yielded significantly more lymph nodes than standard PLND (median: 27.0 vs. 17.0, p0.05). Extended PLND increased readmission rates (28.4% vs. 20.2%, p=0.001) and readmission risk (odds ratio, 1.57; 95% confidence interval [CI], 1.15–2.16, p=0.005). However, subgroup analysis revealed extended PLND significantly improved RFS in patients with p/cRNU (hazard ratio, 0.54; 95% CI, 0.38–0.77; p<0.001).Conclusion: Extended PLND does not provide survival benefits for overall patient population and increases readmission risk but significantly improves RFS in patients with p/cRNU. Tailoring PLND extent based on upper tract disease status is recommended.
- Open Access
- 31 March 2025
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 23 (1) , 88-93
Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study
Purpose: Although bladder cancer occurs three to 4 times more frequently in men than in women, the relative number of deaths compared to incidence is higher in women, suggesting that women have a worse prognosis than men. Emerging evidence indicates that the activity of the sex steroid hormone pathway may play a role in bladder cancer development, with demonstrations that both androgens and estrogens have biological effects on bladder cancer in vitro and in vivo. This study investigates the influence of sex and menopausal status on recurrence and cancer-specific death (CSD) in bladder cancer patients undergoing radical cystectomy (RC).Materials and Methods: This retrospective analysis included 3,913 patients from the Korean Bladder Cancer Study Group Database who underwent RC between 2010 and 2019. Patients were categorized based on gender and menopausal status (≤50 years: premenopausal; >50 years: postmenopausal). Pathological factors, neoadjuvant chemotherapy, recurrence, and CSD rates were analyzed using chi-square and Fisher exact tests.Results: Among the 3,913 patients, 400 (10.2%) were female. Premenopausal females exhibited significantly lower recurrence rates (28.6%) compared to postmenopausal females (45.7%). CSD rates were similarly reduced in premenopausal females (12.0% vs. 22.2% in postmenopausal females). No significant sex differences in recurrence or CSD were observed among premenopausal patients. Pathological T stage, nodal status, and lymphovascular invasion were significantly associated with recurrence in males, while nodal status alone was significant in females. Neoadjuvant chemotherapy was significantly more frequently administered to male patients under the age of 50, while no difference was observed in the administration of neoadjuvant chemotherapy among female patients based on menopausal status.Conclusion: Hormonal changes associated with menopause significantly influence bladder cancer outcomes in women. Premenopausal hormonal environments seem protective, underscoring the need for further research into hormone-driven mechanisms in bladder cancer.
- 31 March 2025
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 23 (1) , 88-93
Open AccessGender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study
Purpose: Although bladder cancer occurs three to 4 times more frequently in men than in women, the relative number of deaths compared to incidence is higher in women, suggesting that women have a worse prognosis than men. Emerging evidence indicates that the activity of the sex steroid hormone pathway may play a role in bladder cancer development, with demonstrations that both androgens and estrogens have biological effects on bladder cancer in vitro and in vivo. This study investigates the influence of sex and menopausal status on recurrence and cancer-specific death (CSD) in bladder cancer patients undergoing radical cystectomy (RC).Materials and Methods: This retrospective analysis included 3,913 patients from the Korean Bladder Cancer Study Group Database who underwent RC between 2010 and 2019. Patients were categorized based on gender and menopausal status (≤50 years: premenopausal; >50 years: postmenopausal). Pathological factors, neoadjuvant chemotherapy, recurrence, and CSD rates were analyzed using chi-square and Fisher exact tests.Results: Among the 3,913 patients, 400 (10.2%) were female. Premenopausal females exhibited significantly lower recurrence rates (28.6%) compared to postmenopausal females (45.7%). CSD rates were similarly reduced in premenopausal females (12.0% vs. 22.2% in postmenopausal females). No significant sex differences in recurrence or CSD were observed among premenopausal patients. Pathological T stage, nodal status, and lymphovascular invasion were significantly associated with recurrence in males, while nodal status alone was significant in females. Neoadjuvant chemotherapy was significantly more frequently administered to male patients under the age of 50, while no difference was observed in the administration of neoadjuvant chemotherapy among female patients based on menopausal status.Conclusion: Hormonal changes associated with menopause significantly influence bladder cancer outcomes in women. Premenopausal hormonal environments seem protective, underscoring the need for further research into hormone-driven mechanisms in bladder cancer.
- Open Access
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43 (1) , 123-133
Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study
Kim JH, et al. World J Mens Health. 2025 Jan;43(1):123-133. https://doi.org/10.5534/wjmh.230237
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43 (1) , 123-133
Open AccessSecondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study
Kim JH, et al. World J Mens Health. 2025 Jan;43(1):123-133. https://doi.org/10.5534/wjmh.230237
- Open Access
- 30 November 2024
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 22 (3) , 196-200
Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Purpose: This study evaluates the viability of a new method that employs transperineal targeted biopsy with frozen section analysis immediately followed by robot-assisted radical prostatectomy (RARP), bypassing the traditional systematic biopsy deemed essential by current guidelines.Materials and Methods: Patient selection was based on the following inclusion criteria: those who underwent magnetic resonance imaging (MRI)-ultrasound fusion-targeted biopsy with frozen section analysis and concurrent RARP. Eligibility also required features indicative of Prostate Imaging-Reporting and Data System (PI-RADS) 5 lesion on multiparametric MRI, along with one of these additional criteria: (1) MRI evidence suggesting extracapsular extension (ECE) with a prostate-specific antigen (PSA) level >10 ng/mL, or (2) a PSA level > 20 ng/mL.Results: Twelve patients were enrolled in this study according to inclusion criteria. The median age (interquartile range) was 73.5 (69.5–75.3) years and PSA was 22.9 (17.0–29.9) ng/mL. Three patients had PI-RADS 5 lesions, and 9 had PI-RADS 5 lesions with findings of ECE. In all cases, the diagnosis based on frozen sections confirmed adenocarcinoma. Following confirmation, each patient underwent immediate RARP. According to the final pathology report, 2 patients had International Society of Urological Pathology (ISUP) grade 2 disease, 7 patients had ISUP grade 3, 1 had ISUP grade 4, and 2 had ISUP grade 5 disease. Four patients had stage pT2 disease, 3 had stage pT3a, and 5 had stage pT3b. The median immediate reporting time of the target biopsy frozen section was 20 (19.3–24.5) minutes. No perioperative complications related to target biopsy were observed.Conclusion: For patients with a strong suspicion of prostate cancer and a PI-RADS 5 lesion, integrating simultaneous prostate frozen target biopsy with radical prostatectomy may offer a feasible treatment alternative, obviating the necessity for a preoperative systematic biopsy.
- 30 November 2024
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 22 (3) , 196-200
Open AccessSimultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Purpose: This study evaluates the viability of a new method that employs transperineal targeted biopsy with frozen section analysis immediately followed by robot-assisted radical prostatectomy (RARP), bypassing the traditional systematic biopsy deemed essential by current guidelines.Materials and Methods: Patient selection was based on the following inclusion criteria: those who underwent magnetic resonance imaging (MRI)-ultrasound fusion-targeted biopsy with frozen section analysis and concurrent RARP. Eligibility also required features indicative of Prostate Imaging-Reporting and Data System (PI-RADS) 5 lesion on multiparametric MRI, along with one of these additional criteria: (1) MRI evidence suggesting extracapsular extension (ECE) with a prostate-specific antigen (PSA) level >10 ng/mL, or (2) a PSA level > 20 ng/mL.Results: Twelve patients were enrolled in this study according to inclusion criteria. The median age (interquartile range) was 73.5 (69.5–75.3) years and PSA was 22.9 (17.0–29.9) ng/mL. Three patients had PI-RADS 5 lesions, and 9 had PI-RADS 5 lesions with findings of ECE. In all cases, the diagnosis based on frozen sections confirmed adenocarcinoma. Following confirmation, each patient underwent immediate RARP. According to the final pathology report, 2 patients had International Society of Urological Pathology (ISUP) grade 2 disease, 7 patients had ISUP grade 3, 1 had ISUP grade 4, and 2 had ISUP grade 5 disease. Four patients had stage pT2 disease, 3 had stage pT3a, and 5 had stage pT3b. The median immediate reporting time of the target biopsy frozen section was 20 (19.3–24.5) minutes. No perioperative complications related to target biopsy were observed.Conclusion: For patients with a strong suspicion of prostate cancer and a PI-RADS 5 lesion, integrating simultaneous prostate frozen target biopsy with radical prostatectomy may offer a feasible treatment alternative, obviating the necessity for a preoperative systematic biopsy.